Everyone seriously engaged in the drug development business knows the odds against success with any experimental new drug. And they certainly can count the costs of lengthy animal safety studies, which can significantly erode a drug's potential revenue post-approval.
Now a new computer-based system is being introduced that can cut down on the amount of time and money it takes to demonstrate drug safety. Working with advanced robotics and software, three federal agencies have perfected a new...